| View |
LRV2024-12-11-0527
|
HUMAN TETANUS IMMUNOGLOBULIN
|
IG TETANO
|
BR-801
|
Q13R3824
|
Packaging Lot (Box and PFS): Q13R3824
|
30-Sep-27
|
17 December 2024
|
| View |
LRV2024-12-12-0533
|
HUMAN NORMAL IMMUNOGLOBULIN
|
IMMUNOREL
|
BRP-052
|
ID05F24006
|
Packaging Lot (Box and Vial): ID05F24006
|
30-Sep-27
|
18 December 2024
|
| View |
2022-10-11-0284
|
PURIFIED CHICK EMBRYO CELL CULTURE RABIES VACCINE
|
VAXIRAB N
|
BRP-071
|
RV20022
|
Packaging Lot (Box & Vial): RV20022; (Diluent): AMW1003
|
30/06/2025
|
17 October 2022
|
| View |
2022-10-11-0285
|
PURIFIED CHICK EMBRYO CELL CULTURE RABIES VACCINE
|
VAXIRAB N
|
BRP-071
|
RV20020
|
Packaging Lot (Box & Vial): RV20020; (Diluent): AMW1003
|
30/06/2025
|
14 October 2022
|
| View |
2018-06-27-0132
|
Human Papillomavirus Vaccine Types 16 and 18 (Recombinant, AsO4 Adjuvant)
|
Cervarix
|
BR-616
|
AHPVA368A
|
Packaging Lot: Box & PFS - AHPVA368AP; Needle (23G x 1") - 1705021 (ED: 2022-05-31)
|
31 August 2021
|
29 June 2018
|
| View |
2019-07-23-0170
|
Live Attenuated Measles, Mumps and Rubella Vaccine
|
-
|
BR-885
|
0159N002
|
Packaging lot - Box and Vials: 0159N002, MD: MAR.2019, ED: AUG.2021; Box & Diluents: 0678S1002, MD: DEC.2018, ED: NOV.2023
|
31 August 2021
|
25 July 2019
|
| View |
2019-11-13-0278
|
Diphtheria, Tetanus and Acellular Pertussis, Inactivated Poliomyelitis and Haemophilus influenzae Type B Conjugate Vaccine, Adsorbed
|
Infanrix-IPV+Hib
|
BR-659
|
A20CB557 (DTPa-IPV: AC20B395A; HiB: AHIBD392B)
|
Packaging lot (box): A20CB557C
Pre-filled syringe: A20LB557C, ED 08-2021
Vial: A20FB557C, MD 07-2019, ED 06-2022;
Needles (25G x 1"): 1907007, ED 2024-06-30
|
31 August 2021
|
15 November 2019
|
| View |
2020-01-15-0008
|
Diphtheria, Tetanus and Acellular Pertussis, Inactivated Poliomyelitis and Haemophilus influenzae Type B Conjugate Vaccine, Adsorbed
|
Infanrix-IPV+Hib
|
BR-659
|
A20CB558 (DTPa-IPV: AC20B395A; HiB: AHIBD393C)
|
Packaging lot (box): A20CB558A
Pre-filled syringe: A20CB558A, ED 08-2021
Vial: A20FB558A, MD 07-2019, ED 06-2022;
Needles (25G x 1"): 1908009, ED 2024-07-31
|
31 August 2021
|
17 January 2020
|
| View |
2020-10-21-0269
|
Diphtheria, Tetanus, Pertussis (Acellular Component), Hepatitis B, Poliomyelitis (Inactivated) and Haemophilus influenzae Type B Conjugate Vaccine (Adsorbed) [DTap-IPV-HepB-Hib]
|
Hexaxim
|
BR-919
|
R3M01
|
Packaging lot: BOX: R3M014V, PFS: R3M01
Needle 25Gx5/8": 2001002, ED: 2024-12-31; Needle 23Gx1": 1909035, ED: 2024-08-31
|
31 August 2021
|
26 October 2020
|
| View |
2020-07-01-0178
|
Diphtheria, Tetanus, Pertussis, Hepatitis B and Haemophilus influenzae Type B Conjugate Vaccine (Adsorbed)
|
-
|
BRP-007
|
2850Y009F
|
Packaging Lot (box and vial): 2850Y009F
|
31 August 2022
|
06 July 2020
|
| View |
2020-07-01-0179
|
Diphtheria, Tetanus, Pertussis, Hepatitis B and Haemophilus influenzae Type B Conjugate Vaccine (Adsorbed)
|
-
|
BRP-007
|
2850Y009E
|
Packaging Lot (box and vial): 2850Y009E
|
31 August 2022
|
06 July 2020
|
| View |
2020-07-01-0180
|
Diphtheria, Tetanus, Pertussis, Hepatitis B and Haemophilus influenzae Type B Conjugate Vaccine (Adsorbed)
|
-
|
BRP-007
|
2850Y009D
|
Packaging Lot (box and vial): 2850Y009D
|
31 August 2022
|
06 July 2020
|
| View |
2020-07-01-0181
|
Diphtheria, Tetanus, Pertussis, Hepatitis B and Haemophilus influenzae Type B Conjugate Vaccine (Adsorbed)
|
-
|
BRP-007
|
2850Y009C
|
Packaging Lot (box and vial): 2850Y009C
|
31 August 2022
|
06 July 2020
|
| View |
2020-07-01-0182
|
Diphtheria, Tetanus, Pertussis, Hepatitis B and Haemophilus influenzae Type B Conjugate Vaccine (Adsorbed)
|
-
|
BRP-007
|
2850Y009B
|
Packaging Lot (box and vials): 2850Y009B
|
31 August 2022
|
06 July 2020
|
| View |
2020-07-01-0183
|
Diphtheria, Tetanus, Pertussis, Hepatitis B and Haemophilus influenzae Type B Conjugate Vaccine (Adsorbed)
|
-
|
BRP-007
|
2850Y009A
|
Packaging Lot (box and vials): 2850Y009A
|
31 August 2022
|
06 July 2020
|
| View |
2020-07-01-0188
|
Diphtheria, Tetanus, Pertussis, Hepatitis B and Haemophilus influenzae Type B Conjugate Vaccine (Adsorbed)
|
None
|
BRP-007
|
2850Y011A
|
Packaging Lot: Box & vial: 2850Y011A
|
31 August 2022
|
07 July 2020
|
| View |
2020-12-09-0319
|
Diphtheria, Tetanus, Pertussis (Acellular Component), Hepatitis B, Poliomyelitis (Inactivated) and Haemophilus influenzae Type B Conjugate Vaccine (Adsorbed) [DTap-IPV-HepB-Hib]
|
Hexaxim
|
BR-919
|
T3M60
|
Packaging Lot: Box - T3M602V; PFS - T3M60; Needle (25G x 5/8") - 2003008 [ED: 2025-02-28]; Needle (23G x 1") - 2002051 [ED: 2025-01-31]
|
31 August 2022
|
11 December 2020
|
| View |
2021-02-26-0089
|
Inactivated Poliomyelitis Vaccine (Types 1, 2 and 3)
|
IMOVAX POLIO
|
BR-498
|
T2A85
|
Packaging Lot (Box): T2V852V; (PFS): T2A85
|
31 August 2022
|
03 March 2021
|
| View |
2021-05-11-0208
|
INACTIVATED POLIOMYELITIS VACCINE (TYPES 1, 2 AND 3)
|
IMOVAX POLIO
|
BR-498
|
U3L29
|
Packaging Lot (Box): U3L291V; (PFS): U3L29
|
31 August 2023
|
14 May 2021
|
| View |
2021-05-26-0239
|
RANIBIZUMAB
|
LUCENTIS
|
BR-1072
|
SXX28
|
Packaging lot (Box & Vial): SAYJ1; Needle: 9351497
|
31 August 2023
|
27 May 2021
|